---
$id: https://graph.org.ai/products/commodity/51142021
$type: Product
source: UNSPSC
code: "51142021"
title: "Bicifadine"
class: "51142000"
classTitle: "Non narcotic analgesics and antipyretics"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Bicifadine

**UNSPSC Code**: 51142021
**Class**: [Non narcotic analgesics and antipyretics](Non narcotic analgesics and antipyretics.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an analgesic agent with the molecular formula C12H15N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B0SV3N7J3H, chemically known as 3-azabicyclo(3.1.0)hexane, 1-(4-methylphenyl)-, (+-)- but generally known as bicifadine, which bears US NIH Compound Identifier 47953. Bicifadine most often comes in base and hydrochloride forms. European Medicines Agency schedules Bicifadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05818MIG. The term BICIFADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 14, No. 1, 2000, List 43). BICIFADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bicifadine under HS 29339990 and SITC 51577. As of Q4 2014, BICIFADINE remains the US FDA Preferred Term for this commodity. Bicifadine bears US NLM identifiers UMLS ID C0053551 and NCI Concept Code C79930. SMILES: CC1=CC=C(C=C1)C23CC2CNC3.

